Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

Autor: Gabriela B. Thoennissen, Martin Kropff, Nils H. Thoennissen, Matthias Stelljes, Fleur Fritz, Georg Evers, Dennis Görlich, Wolfgang E. Berdel, Ulrike Bacher, Utz Krug, Anne-Christin Hüsken, Rolf M. Mesters, Jan-Henrik Mikesch, Anna Hansmeier, Carsten Bokemeyer, Carsten Müller-Tidow, Thomas Aufenberg

Publikováno v: Thoennissen, Gabriela B; Görlich, Dennis; Bacher, Vera Ulrike; Aufenberg, Thomas; Hüsken, Anne-Christin; Hansmeier, Anna Antonia; Evers, Georg; Mikesch, Jan-Henrik; Fritz, Fleur; Bokemeyer, Carsten; Müller-Tidow, Carsten; Stelljes, Matthias; Mesters, Rolf M; Krug, Utz; Kropff, Martin H; Thoennissen, Nils H; Berdel, Wolfgang E (2017). Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis. Acta haematologica, 137(3), pp. 163-172. Karger 10.1159/000463534

Within this retrospective single-center study, we analyzed the survival of 320 multiple myeloma (MM) patients receiving melphalan high-dose chemotherapy (HDCT) and either single (n = 286) or tandem (n = 34) autologous stem cell transplantation (ASCT)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba7a80fb33c12dd2189d72d120d83a3